No clear link between VKORC1 genetic polymorphism and the risk of venous thrombosis or peripheral arterial disease

Thromb Haemost. 2008 May;99(5):970-2. doi: 10.1160/TH07-12-0742.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Anticoagulants / therapeutic use
  • Case-Control Studies
  • Drug Resistance
  • Female
  • Gene Frequency
  • Genetic Predisposition to Disease
  • Haplotypes
  • Humans
  • Male
  • Mixed Function Oxygenases / genetics*
  • Odds Ratio
  • Peripheral Vascular Diseases / drug therapy
  • Peripheral Vascular Diseases / genetics*
  • Polymorphism, Single Nucleotide*
  • Promoter Regions, Genetic
  • Risk Assessment
  • Risk Factors
  • Venous Thromboembolism / drug therapy
  • Venous Thromboembolism / genetics*
  • Venous Thrombosis / drug therapy
  • Venous Thrombosis / genetics*
  • Vitamin K Epoxide Reductases
  • Warfarin / therapeutic use

Substances

  • Anticoagulants
  • Warfarin
  • Mixed Function Oxygenases
  • VKORC1 protein, human
  • Vitamin K Epoxide Reductases